Pyrvinium Pamoate: Past, Present, and Future As an Anti-Cancer Drug

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Dec 23

PMID 36552005

Authors

Christopher W Schultz

Avinoam Nevler

Affiliations

Soon will be listed here.

Abstract

Pyrvinium, a lipophilic cation belonging to the cyanine dye family, has been used in the clinic as a safe and effective anthelminthic for over 70 years. Its structure, similar to some polyaminopyrimidines and mitochondrial-targeting peptoids, has been linked with mitochondrial localization and targeting. Over the past two decades, increasing evidence has emerged showing pyrvinium to be a strong anti-cancer molecule in various human cancers in vitro and in vivo. This efficacy against cancers has been attributed to diverse mechanisms of action, with the weight of evidence supporting the inhibition of mitochondrial function, the WNT pathway, and cancer stem cell renewal. Despite the overwhelming evidence demonstrating the efficacy of pyrvinium for the treatment of human cancers, pyrvinium has not yet been repurposed for the treatment of cancers. This review provides an in-depth analysis of the history of pyrvinium as a therapeutic, the rationale and data supporting its use as an anticancer agent, and the challenges associated with repurposing pyrvinium as an anti-cancer agent.

Citing Articles

Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti-Pancreatic Cancer Activity in 2D and 3D Cell Culture Models.

Serala K, Bai J, Prince S J Cell Mol Med. 2024; 28(23):e70222.

PMID: 39632282 PMC: 11617115. DOI: 10.1111/jcmm.70222.

Drug Repurposing for Cancer Treatment: A Comprehensive Review.

Al Khzem A, Gomaa M, Alturki M, Tawfeeq N, Sarafroz M, Alonaizi S Int J Mol Sci. 2024; 25(22).

PMID: 39596504 PMC: 11595001. DOI: 10.3390/ijms252212441.

Unlocking Benzosampangine's Potential: A Computational Approach to Investigating, Its Role as a PD-L1 Inhibitor in Tumor Immune Evasion via Molecular Docking, Dynamic Simulation, and ADMET Profiling.

Ouchaoui A, El Hadad S, Aherkou M, Fadoua E, Mouad M, Ramli Y Bioinform Biol Insights. 2024; 18:11779322241298591.

PMID: 39564188 PMC: 11574905. DOI: 10.1177/11779322241298591.

A High-Throughput Drug Repurposing Strategy to Treat TBX2 and/or TBX3 Dependent Cancers.

Bleloch J, Lu S, Khan S, Serala K, Seraia E, Millar V Cancer Med. 2024; 13(19):e70303.

PMID: 39403898 PMC: 11474296. DOI: 10.1002/cam4.70303.

Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses.

Lopez-Cortes A, Cabrera-Andrade A, Echeverria-Garces G, Echeverria-Espinoza P, Pineda-Alban M, Elsitdie N Sci Rep. 2024; 14(1):19359.

PMID: 39169044 PMC: 11339426. DOI: 10.1038/s41598-024-68565-7.

References

Yi Y, Woo Y, Hwang K, Kim H, Lee S . Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt-Axin2-Snail Cascade. Cancers (Basel). 2021; 13(18). PMC: 8464802. DOI: 10.3390/cancers13184630. View

Faheem S, El-Sayed N, Moustafa Y, Saeed N, Hazem R . Pyrvinium pamoate ameliorates cyclosporin A- induced hepatotoxicity via the modulation of Wnt/β-catenin signaling and upregulation of PPAR-γ. Int Immunopharmacol. 2022; 104:108538. DOI: 10.1016/j.intimp.2022.108538. View

Wu X, Li F, Wang X, Li C, Meng Q, Wang C . Antibiotic bedaquiline effectively targets growth, survival and tumor angiogenesis of lung cancer through suppressing energy metabolism. Biochem Biophys Res Commun. 2017; 495(1):267-272. DOI: 10.1016/j.bbrc.2017.10.136. View

Guan Q, Zhan L, Liu Z, Pan Q, Chen X, Xiao Z . Identification of pyrvinium pamoate as an anti-tuberculosis agent and by SOSA approach amongst known drugs. Emerg Microbes Infect. 2020; 9(1):302-312. PMC: 7034053. DOI: 10.1080/22221751.2020.1720527. View

Sun Y, Gao L, Zhang Y, Yang J, Zeng T . Synergistic Effect of Pyrvinium Pamoate and Azoles Against and . Front Microbiol. 2020; 11:579362. PMC: 7669749. DOI: 10.3389/fmicb.2020.579362. View

Valle S, Alcala S, Martin-Hijano L, Cabezas-Sainz P, Navarro D, Munoz E . Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells. Nat Commun. 2020; 11(1):5265. PMC: 7567808. DOI: 10.1038/s41467-020-18954-z. View

Sil D, Panja S, Jogdeo C, Kumar R, Yu A, Holbert C . Self-Assembled Alkylated Polyamine Analogs as Supramolecular Anticancer Agents. Molecules. 2022; 27(8). PMC: 9032695. DOI: 10.3390/molecules27082441. View

Srivastava S, Yadav S, Singh G, Bajwa S . Wnt/β-catenin antagonist pyrvinium rescues high dose isoproterenol induced cardiotoxicity in rats: Biochemical and immunohistological evidences. Chem Biol Interact. 2022; 358:109902. DOI: 10.1016/j.cbi.2022.109902. View

Dattilo R, Mottini C, Camera E, Lamolinara A, Auslander N, Doglioni G . Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism. Cancer Res. 2020; 80(19):4087-4102. PMC: 8808379. DOI: 10.1158/0008-5472.CAN-19-1184. View

10.

Thompson P, WORLEY D, MEISENHELDER J . Anthelmintic studies on pyrvinium pamoate (Povan) and other drugs in rodents, dogs, and monkeys. Am J Trop Med Hyg. 1962; 11:89-95. DOI: 10.4269/ajtmh.1962.11.89. View

11.

Wang C, GALLI G . STRONGYLOIDIASIS TREATED WITH PYRVINIUM PAMOATE. JAMA. 1965; 193:847-8. DOI: 10.1001/jama.1965.03090100093040. View

12.

Zarei M, Lal S, Parker S, Nevler A, Vaziri-Gohar A, Dukleska K . Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells. Cancer Res. 2017; 77(16):4460-4471. PMC: 5922269. DOI: 10.1158/0008-5472.CAN-17-0015. View

13.

Gaikwad V, Karale U, Govindarajalu G, Adhikari N, Krishna E, Krishna V . Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens. Bioorg Med Chem Lett. 2020; 30(8):127037. DOI: 10.1016/j.bmcl.2020.127037. View

14.

Tomitsuka E, Kita K, Esumi H . An anticancer agent, pyrvinium pamoate inhibits the NADH-fumarate reductase system--a unique mitochondrial energy metabolism in tumour microenvironments. J Biochem. 2012; 152(2):171-83. DOI: 10.1093/jb/mvs041. View

15.

Sen P, Gupta K, Kumari A, Singh G, Pandey S, Singh R . Wnt/β-Catenin Antagonist Pyrvinium Exerts Cardioprotective Effects in Polymicrobial Sepsis Model by Attenuating Calcium Dyshomeostasis and Mitochondrial Dysfunction. Cardiovasc Toxicol. 2021; 21(7):517-532. DOI: 10.1007/s12012-021-09643-4. View

16.

Taipale J, Beachy P . The Hedgehog and Wnt signalling pathways in cancer. Nature. 2001; 411(6835):349-54. DOI: 10.1038/35077219. View

17.

Downey A, Chong C, Graczyk T, Sullivan D . Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model. Antimicrob Agents Chemother. 2008; 52(9):3106-12. PMC: 2533469. DOI: 10.1128/AAC.00207-08. View

18.

AUR R . Treatment of parasitic infestation in children with malignant neoplasms. J Pediatr. 1971; 78(1):129-31. DOI: 10.1016/s0022-3476(71)80278-0. View

19.

Li H, Liu S, Jin R, Xu H, Li Y, Chen Y . Pyrvinium pamoate regulates MGMT expression through suppressing the Wnt/β-catenin signaling pathway to enhance the glioblastoma sensitivity to temozolomide. Cell Death Discov. 2021; 7(1):288. PMC: 8511032. DOI: 10.1038/s41420-021-00654-2. View

20.

Wiegering A, Uthe F, Huttenrauch M, Muhling B, Linnebacher M, Krummenast F . The impact of pyrvinium pamoate on colon cancer cell viability. Int J Colorectal Dis. 2014; 29(10):1189-98. DOI: 10.1007/s00384-014-1975-y. View